.jpg)
Listen: The U.K.’s vaccine push, how to cover the pandemic, and a DNA detective story
How soon will we get a Covid-19 vaccine? Why is biotech moving airline stocks? And…
Category: The Readout LOUD
‘We have to do a better job’: How structural racism in medicine harms both doctors and patients
Early in her medical career, physician Rachel Issaka encountered a liver transplant patient who was…
Listen: Coronavirus vaccine data, saving the U.S.’s pandemic response, and systemic racism in medicine
What do we want from a coronavirus vaccine? Can the U.S.’s Covid-19 response be saved?…
Listen: Trump’s FDA pressure, a microcosm of the pandemic, and squabbling over a vaccine
Who will stand up to the White House? How can hospitals protect workers from Covid-19?…
Listen: Remdesivir’s controversial cost, early vaccine promise, and AI at the end of life
What’s a fair price for remdesivir? How do we know whether vaccines work? And does…
Listen: Covid-19’s U.S. surge, GSK’s mystery whistleblower, and cancer care under coronavirus
Is this a second wave or a rising tide? Who’s the real GlaxoSmithKline whistleblower? And…
STAT Plus: STAT+ Conversations: The Readout LOUD, Live!
Editor’s note: The livestream of this conversation will be embedded below at 1 p.m. ET. …
He speaks at Black churches about genetics — and has some ideas about how to fix his field’s diversity problem
Over the past few weeks, 23andMe and other genetic testing companies have made headlines for…
Listen: The latest on treating Covid-19, vaccine politics, and diversifying genetics
Can a vaccine be an October surprise? Are journal publishers running a racket? And why…
The Chan-Zuck uprising, a virtual BIO, and the struggle to treat Covid-19
Can a virtual conference feel real? Do scientists have a say in their benefactors’ business?…
Listen: The killing of George Floyd, the drug industry’s response, and what comes next
We’re going to do something different on this episode of “The Readout LOUD,” STAT’s biotech…
Listen: Life after a coronavirus vaccine, virtual ASCO, and remembering Larry Kramer
What happens after we get a coronavirus vaccine? Can virtual medical meetings replace the real…
Listen: Moderna’s scant coronavirus data, the plight of the day trader, and the world’s dependence on biotech
When is a press release worth $5 billion? Can biotech stocks replace sports? And how…
Listen: Covid-19 in the White House, an audacious approach to Parkinson’s, and the public health lessons from porn
What can the adult film industry teach us about fighting coronavirus? Does the FDA approve…
Listen: How bad will the pandemic get? Plus: Gilead’s pricing dilemma and fighting Covid-19 in New York
What if the curve just stays flat? How much should a Covid-19 drug cost? And…
Listen: Scott Gottlieb on Covid-19 treatments, reopening America, and going on TV every day
Just how well does Gilead Sciences’ Covid-19 drug work? Is politics getting in the way…
Listen: The ousting of a vaccine official, how to use ventilators, & the fate of the JP Morgan conference
Why was the infectious disease community in denial about the unfolding pandemic? When can we…
Listen: Coronavirus disrupts D.C., how not to be boring on Zoom, and the trial of Elizabeth Holmes
What’s the proper distance to stand from Sen. Mitch McConnell? How many PowerPoint charts is…
Listen: Privacy in a pandemic, biopharma’s big opportunity, and Shkreli’s plea for a break
Can the drug industry win over Americans? Will the pandemic put an end to privacy?…
Listen: Pandemic exit strategies, how the outbreak affects patients, and Ken Burns takes on DNA
When will things go back to normal? What if a pandemic strikes when you’re already…
Listen: Fauci’s star turn, the latest on coronavirus, and an under-the-radar Alzheimer’s drug
When can we stop distancing? Does the “deep state” meet over Zoom? And could the…
Listen: Trump’s coronavirus pivot, life inside the ICU, drug development in a pandemic
Why did the U.S. change its tune on coronavirus? What’s it like to be an…
Listen: Voices from the coronavirus pandemic, in Italy, New York, and the high seas
How long will this pandemic persist? Are U.S. hospitals going to be overwhelmed? And what’s…
Listen: Pharma’s response to coronavirus, Google’s appetite for health data, and biotech’s rise in China
Does “The Art of the Deal” cover vaccines? Is patient privacy a relic of the…
Listen: Wall Street’s coronavirus freakout, why clinical trials frustrate patients, and a journey through the past
Is the market overreacting to the coronavirus? Why do so many clinical trials go unfilled?…
Listen: Drug industry infighting, the human side of genetic medicine, and a big year for the microbiome
Can biopharma police itself? Who decides whether something’s a disease or a difference? And will…
The Zolgensma lottery, billionaire philanthropy, & life on the buy side
What’s the right way to give drugs away? Is $3 billion even a lot of…
Listen: Fake outbreak news, treating coronavirus, and biotech’s Mount Rushmore
Is peer review underrated? Can biotech stop an outbreak? And would you mind giving us…
Listen: A chemist breaks bad, the latest on the coronavirus, and pharma’s slow Bern
Is it wise to lie to the feds? Is pharma taking Sen. Bernie Sanders seriously?…
STAT Plus: What does the latest twist in the Sarepta saga mean for the future of the FDA? We discuss
Earlier this week, the Food and Drug Administration released documents that reveal a schism within…
Listen: The latest on the China virus, Sarepta’s ongoing FDA saga, and biotech at Davos
Are we dealing with a SARS redux? Has the FDA lost its teeth? And what…
Listen: A J.P. Morgan recap, a plan to bust pharma monopolies, and a website for cancer patients
Why weren’t there any big deals announced this week? What does the word “equivalar” mean?…
Listen: Biohacker Josiah Zayner on getting canceled, good news in cancer, and a long road in Ebola
Does pharma deserve more credit? Will history forgive He Jiankui? And how does a laboratory…
Listen: The decade in breakthrough drugs, the year in bad CEOing, and the viruses that cure disease
Which drug defined the decade? Who’s the worst CEO in biopharma? And how does gene…
Listen: Biogen’s big reveal, hot takes on Alzheimer’s, & the science of one-eyed sheep
How do you know if a “positive” study is positive? And what if clinical trial…
Listen: Warren’s awkward home front, the ethics of treating dwarfism, and the sound of STAT Summit
Can Sen. Elizabeth Warren ever go home again? Is it ethical to make little people…